Meeting
2023 ASCO Genitourinary Cancers Symposium
Development and validation of a multigenomic liquid biopsy (PROSTest) for prostate cancer detection.
Authors
Irvin Mark Modlin
Yale University, New Haven, CT
Irvin Mark Modlin , Mark Kidd , Ignat A. Drozdov , Martin Boegemann , Lisa Bodei , Jolanta Kunikowska , Anna Malczewska , Christof Bernemann , Kambiz Rahbar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 252)
DOI
10.1200/JCO.2023.41.6_suppl.252
Abstract #
252
Poster Bd #
J12
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
A blood-based multi-mRNA liquid biopsy with >90% accuracy for diagnosis and assessment of prostate cancers.
First Author: Kambiz Rahbar
Poster
2024 ASCO Genitourinary Cancers Symposium
A novel blood-based mRNA genomic test for screening, early detection, prognosis, and monitoring of prostate cancer: A multicenter study.
First Author: Yutaka Hashimoto
Poster
2024 ASCO Genitourinary Cancers Symposium
Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer.
First Author: Ekamjit Singh Deol
Poster
2024 ASCO Genitourinary Cancers Symposium
Prostate extracellular vesicles and prediction of clinically significant prostate cancer: A prospective single-institution pilot study.
First Author: Cameron J Britton